Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: A prospective, randomized, open-label, cross-over study

BACKGROUND: Trimetazidine (TMZ) modulates cardiac metabolism, but its use in heart failure remains controversial. The aim of the study was to evaluate the effects of TMZ on exercise capacity, left ventricular ejection fraction (LVEF), mortality, and quality of life in stable patients with heart fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohdan, Michał, Stopczyńska, Iwona, Wiśniewski, Piotr, Moryś, Joanna, Niedoszytko, Piotr, Gruchała, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273257/
https://www.ncbi.nlm.nih.gov/pubmed/33200813
http://dx.doi.org/10.5603/CJ.a2020.0165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273257/
https://www.ncbi.nlm.nih.gov/pubmed/33200813
http://dx.doi.org/10.5603/CJ.a2020.0165

Ejemplares similares